Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-01-09 @ 6:21 AM
Study NCT ID:
NCT05265650
Status:
UNKNOWN
Last Update Posted:
2022-07-19
First Post:
2022-02-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC
Sponsor:
Clinica Universidad de Navarra, Universidad de Navarra
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BORT-112
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |